Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
GHK-Cu structure

GHK-Cu

Healing & Recovery
Phase 2 Research
50%
Low Risk
1/5

Dosing Protocol

Typical Dose 1.5 mg
Range 1 - 2 mg
Maintenance 1 mg daily
Cycle 8w on / 8w off

Pharmacokinetics

Half-Life 45 min
Onset 10 min
Peak 15 min
Duration 3.0 hrs
Bioavailability 90%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Topical
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Morning, Evening

Reconstitution

Diluent Bacteriostatic Water
Volume 3 mL
Concentration 16667 mcg/mL
Stability 30 days refrigerated
Vial Sizes 50 mg

Special Instructions

Also available as topical cream (2-10% concentration). Cycle 8-12 weeks on, equal time off to maintain receptor sensitivity.